2022 annual financial data
Rani Therapeutics Holdings 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -63,451,000 USD and net income was -30,588,000 USD.
Operating cash flow was -46,515,000 USD.
Get free Rani Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -63,451,000 USD
- Net income
- -30,588,000 USD
- Operating cash flow
- -46,515,000 USD